Vitalizer
NDC 43857-0629, Echinacea (Angustifolia), Iodium, Arsenicum Album, Aurum Metallicum, Calcarea Fluorica, Gallicum Acidum, Hekla Lava, Niccolum Sulphuricum, Phosphorus, Sedum Acre, Sempervivum Tectorum, Senecio Aureus, Blatta Americana, Onosmodium Virginianum, liquid, from BioActive Nutritional, Inc..
- Product NDC
- 43857-0629
- Status
- Listed
- Labeler
- BioActive Nutritional, Inc.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43857-0629 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ECHINACEA ANGUSTIFOLIA WHOLE3 [hp_X]/mL
- IODINE6 [hp_X]/mL
- ARSENIC TRIOXIDE12 [hp_X]/mL
- GOLD12 [hp_X]/mL
- CALCIUM FLUORIDE12 [hp_X]/mL
- GALLIC ACID MONOHYDRATE12 [hp_X]/mL
- HEKLA LAVA12 [hp_X]/mL
- NICKEL SULFATE HEXAHYDRATE12 [hp_X]/mL
- PHOSPHORUS12 [hp_X]/mL
- SEDUM ACRE WHOLE12 [hp_X]/mL
- SEMPERVIVUM TECTORUM LEAF12 [hp_X]/mL
- PACKERA AUREA WHOLE12 [hp_X]/mL
- PERIPLANETA AMERICANA16 [hp_X]/mL
- ONOSMODIUM VIRGINIANUM30 [hp_C]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Insect Proteins [CS]; Non-Standardized Insect Allergenic Extract [EPC]; Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43857-0629-1 | 43857062901 | 30 mL in 1 BOTTLE, DROPPER (43857-0629-1) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 43857-0629 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43857-0629 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43857-0629. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.